Resveratrol and Cervical Cancer: A New Therapeutic Option

Author:

Mirzaei Hamed1,Asemi Zatollah1,Shafabakhsh Rana1,Reiter Russel J.2,Aschner Michael3

Affiliation:

1. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran

2. Department of Cellular and Structural Biology, University of Texas Health Science, Center, San Antonio, TX, USA

3. Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA

Abstract

Abstract: Globally, cervical cancer is the second most common cancer and the third main cause of death related to cancer in women. The cervical cancer mortality rate is higher in underdeveloped and developing vs. developed countries. Chronic infection with human papilloma virus (HPV) can trigger cervical cancer, by an interplay of a variety of pathways and molecules (i.e., inflammatory mediators, oxidative stress and apoptosis) leading to carcinogenesis and cancer progression. Cervical carcinoma is treatable in early stages, while it progresses to metastasis at advanced stages; however, generally it is poorly manageable with current treatment options. For future advances in the treatment of metastatic or recurrent cervical cancer carcinoma, identification of new therapeutic platforms is necessary. A new generation of drugs, herbs and spices afford novel opportunities for cancer therapy. Among the herb-based components, resveratrol has several beneficial effects given its anti-cancer activities (e.g., anti-angiogenesis, anti-proliferation, anti-metastatic and pro-apoptotic). Hence, this therapeutic agent may have promising potential if clinically corroborated to possess anti-cancer efficacy. Here, we summarize the chemopreventive and treatment actions of resveratrol for cervical cancer as well as its mechanism of action.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3